Evolent Health (EVH) Stock Statistics & Valuation Metrics

Evolent Health has a market cap or net worth of $445.43M. The enterprise value is $1.26B.

Evolent Health has 112,481,064 shares outstanding. The number of shares has decreased by -2.65% in one year.

Evolent Health’s return on equity (ROE) is -1.29 and return on invested capital (ROIC) is -0.29%.

The current PE Ratio of Evolent Health is ―. Evolent Health’s PEG ratio is -0.00163.

In the last 12 months, Evolent Health had revenue of 1.88B and earned -534.51M in profits. Earnings per share was -5.07.

In the last 12 months, operating cash flow was 33.29M and capital expenditures -31.90M, giving a free cash flow of 1.40M billion.

Evolent Health pays an annual dividend of ―, resulting in a dividend yield of ―

Evolent Health upcoming earnings date is Aug 5, 2026, After Close (Confirmed).

Evolent Health as a current ratio of 1.31, with Debt / Equity ratio of 248.60%

In the past 12 months, Evolent Health has paid -126.00K in taxes.

Evolent Health EV to EBITDA ratio is 11.62, with an EV/FCF ratio of 272.28.

Evolent Health has $166.00M in cash and marketable securities with $985.42M in debt, giving a net cash position of -$819.42M billion.

Gross margin is 14.13%, with operating margin of -0.24%, and net profit margin of -28.49%.

The average price target for Evolent Health is $5.85, which is 11.43% higher than the current price. The consensus rating is Strong Buy